AptarGroup, Inc. (Aptar) engages in the design and manufacture of drug and consumer product dosing, dispensing and protection technologies.
Aptar serves a number of attractive end markets, including pharmaceutical, beauty, food, beverage, personal care, and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world's leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millio...
AptarGroup, Inc. (Aptar) engages in the design and manufacture of drug and consumer product dosing, dispensing and protection technologies.
Aptar serves a number of attractive end markets, including pharmaceutical, beauty, food, beverage, personal care, and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world's leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world.
The company’s business includes manufacturing and selling aerosol valves in the United States and has grown primarily through acquisitions and organic growth. The company has manufacturing facilities located throughout the world, including North America, Europe, Asia and Latin America. The company has approximately 5,000 customers. Many of the company’s product solutions for the beauty, personal care, home care, food and beverage markets are recyclable, reusable or made with recycled content.
The company partners with its customers by providing innovative solutions and end market expertise. While it offers a wide variety of services and products, the company’s primary products are dispensing pumps, closures, aerosol valves, elastomeric primary packaging components, active material science solutions and digital health solutions.
Dispensing pumps are finger-actuated dispensing systems that dispense a spray or lotion from non-pressurized containers. The style of pump used depends largely on the nature of the product being dispensed, from small, fine mist pumps used with pharmaceutical products and perfume to lotion pumps for more viscous formulas.
Closures are primarily dispensing closures but to a lesser degree can include non-dispensing closures. Dispensing closures are plastic caps that allow a product to be dispensed without removing the cap.
Aerosol valves dispense product from pressurized containers. The majority of the aerosol valves that the company sells are continuous spray valves, with the balance being metered dose valves and bag-on valves.
The company also manufactures and sells elastomeric primary packaging components. These components are used in the injectables market. Products include stoppers for infusion, antibiotic, lyophilization and diagnostic vials. The company’s elastomeric components also include pre-filled syringe components, such as plungers, needle shields, tip caps and components for cartridges.
The company specializes in active material science innovations for the healthcare and pharmaceutical industries. Leveraging its proprietary highly engineered active polymer technologies, the company enables enhanced mitigation of impurities and degradation, product stability, shelf life, and performance from medical device and drug delivery to food protection applications.
The company’s digital health solutions aim to improve patients' treatment experience and outcomes. The company leverages companion and regulated software solutions, connected devices and diagnostic tools that support patients to manage their disease, as well as enabling care teams to remotely monitor the health of the patients when needed. Available as standalone or as a fully integrated offering in the company’s existing range of drug delivery solutions, the company has digital health solutions covering a wide range of therapeutic areas, including but not limited to, pulmonary, oncology, neurology, diabetes, immunology and rare disease.
Acquisitions
In October 2024, the company acquired 40% of the equity interests in Ningbo Jinyu Technology Industry Co., Ltd., doing business as Goldrain, (referred to herein as ‘Goldrain’).
Strategy
The key elements of the company’s strategy are to focus on organic growth with an added focus in high growth regions; excellence in core business functions; and continue to focus on growing it through appropriate business acquisition opportunities, as well as developing partnerships to expand the scope of its technologies, geographic presence and product offerings.
Segments
The company operates through three segments: Aptar Pharma, Aptar Beauty, and Aptar Closures.
Aptar Pharma segment
Aptar Pharma segment is a supplier of nasal drug delivery spray pumps and metered dose inhaler valves (‘MDIs’) to the pharmaceutical and health care markets worldwide. The company is an important supplier of elastomer for injectable primary packaging components worldwide. The company also provides services designed to accelerate and de-risk the development and regulatory approvals of drugs using drug delivery devices.
Characteristics of this market include governmental regulation of the company’s pharmaceutical customers, contaminant-controlled manufacturing environments and a significant amount of time and research from initially working with pharmaceutical companies at the molecular development stage of a medication through the eventual distribution to the market.
The company has clean-room manufacturing facilities in Argentina, China, France, Germany, India, Switzerland and the United States. Providing value-added, convenient drug delivery and dispensing systems will continue to offer opportunities for the company’s business. In addition, there are opportunities for growth in the over-the-counter and generic pharmaceutical categories.
Prescription Drug
Sales to the prescription drug market accounted for approximately 49% of the segment’s total net sales in 2024.
Pumps sold to the prescription drug market deliver medications nasally, orally or topically. The majority of the company’s pumps sold are for nasal allergy treatments. Sales of pumps to deliver prescription allergy medicine that is now available over-the-counter remains part of the company’s prescription drug division. The company’s nasal pumps and unit dose and bidose devices are also used to deliver liquid and powder pain management, emergency medicines and central nervous system therapies.
MDIs are used for dispensing precise amounts of aerosolized medication. This technology allows medication to be broken up into very fine particles, which enables the drug to be delivered typically via the pulmonary route. The majority of the company’s MDIs sold are used for respiratory ailments, such as asthma and chronic obstructive pulmonary disease (COPD).
The company continues to develop proprietary drug delivery systems and accessories in this division. While the company expects that these types of new products will come to market in the future, it is difficult to estimate when, as the rigors of pharmaceutical regulations affect the timing of product introductions by the company’s pharmaceutical customers that use the company’s proprietary drug delivery systems.
Consumer Health Care
Sales to the consumer health care market accounted for approximately 22% of the segment’s total net sales in 2024.
Many product applications for this market are similar to the prescription market proprietary drug delivery systems, however, these product applications are sold over-the-counter without a prescription. Typical consumer health care spray product applications include nasal decongestants, nasal salines and cough and cold products. Typical consumer health care valve product applications include nasal saline using the company’s bag-on valve technology. The company has developed a multi dose ophthalmic dispensing device suitable for unpreserved formulations. Other products sold to this market include airless pump systems for dermal drug delivery product applications. The company continues to see trends toward more child resistant and senior-friendly packaging solutions and have developed products to meet these market needs.
Injectables
Sales to the injectables market accounted for approximately 17% of the segment’s total net sales in 2024.
Injectables are elastomeric primary packaging components that assist with the administration of injected medicines. Injectable products offered include stoppers for vials and pre-filled syringe components, such as plungers, rigid needle shields, tip caps and plungers for cartridges. The company’s recent capital investment commitments in this business have enabled it to bring to market a broader offering of higher value products, including coated stoppers and plungers (PremiumCoat) which better protect the contents of the primary packaging container and the integrity of biologic formulations. Pharmaceutical applications for this market include vaccines, anti-thrombotic, small molecules, GLP-1 and biologics.
Active Material Science Solutions
Sales of active material science solutions products accounted for approximately 11% of the segment’s total net sales in 2024.
The company’s three-phase Active-Polymer technology solution is used to protect oral solid dose drugs, medical devices, diabetes test strips, diagnostics, and probiotics vials, as well as wearable continuous glucose monitors. It can be engineered to absorb moisture, emit aromas, reduce pathogens, or scavenge odor, oxygen or volatile organic compounds.
Digital Health Solutions
Sales to the digital health market accounted for approximately 1% of the segment's total net sales in 2024.
The digital health solutions the company provides improve patients' treatment, experience and outcomes. The company leverages connected devices, diagnostics and digital therapeutic tools that support patients in managing their disease as well as enable care teams to remotely monitor the health of the patients when needed. Available as standalone or as a fully integrated offering in the company’s existing range of drug delivery solutions, the company has digital health solutions covering a wide range of therapeutic areas including, but not limited to, pulmonary, oncology, diabetes, immunology and neurology.
Aptar Beauty segment
Aptar Beauty segment sells a broad variety of pumps, airless systems and valves to the fragrance, color cosmetics, facial skincare, personal care and home care markets. The company is a supplier for the majority of the products it sells primarily to the beauty markets.
Fragrance, Facial Skincare, Color Cosmetics
Sales to these markets accounted for approximately 61% of the segment’s total net sales in 2024.
The fragrance, facial skincare, and color cosmetics markets require a broad range of spray and lotion pumps and sampling dispensing systems to meet functional, as well as aesthetic requirements. A considerable amount of research and coordination with the company’s customers is required to qualify a pump for use with their products. Within the market, the company expects the use of pumps to continue to increase, particularly in the fragrance, facial skincare and sampling sectors. Packaging for certain products, such as natural and organic cosmetics, dermo-cosmetic formulas and anti-aging lotions continue to provide the company with growth opportunities. The company is a leading provider of packaging solutions for prestige and mass market fragrance products. The company’s cosmetic lotion pumps, airless dispensing systems, and decorative capabilities are also expected to provide growth opportunities.
Personal Care
Sales to the personal care market accounted for approximately 35% of the segment’s total net sales in 2024 and primarily included sales of lotion pumps, spray pumps and continuous spray aerosol valves.
Personal care lotion pump product applications include hand sanitizers, hand soaps, bath and shower cleansers and skin moisturizers. Typical spray pump product applications include hair care, body care and sun care products. Personal care continuous spray aerosol valve product applications include hair care products, deodorants, shaving creams and sun care products. The company’s research and development teams continue to design unique accessories that increase the value of the company’s continuous spray aerosol valve offerings.
Home Care
Sales to the home care market accounted for approximately 4% of the segment’s total net sales in 2024 and primarily included sales of continuous or metered dose spray aerosol valves, and, to a lesser degree, spray and lotion pumps.
Product applications for continuous spray valves include disinfectants, spray paints, insecticides and automotive products. Metered dose valves are used for air fresheners. Spray and lotion pump product applications primarily include household cleaners, insect repellent and industrial cleaners.
Aptar Closures segment
Aptar Closures segment primarily sell dispensing closures.
The Aptar Closures business serves multiple markets, including food, beverage, personal care, home care, beauty and healthcare. Aptar's food protection business and its elastomeric flow-control technology business continues to report through the Aptar Closures segment.
In recent years, sales of dispensing closures have grown as consumers worldwide have demonstrated a preference for a package utilizing the convenience of a dispensing closure. At the same time, consumer marketers are trying to differentiate their products by incorporating performance enhancing features, such as flow-control and no-drip dispensing, e-commerce capable solution, inverted packaging and directional flow to make packages simpler to use, cleaner and more appealing to consumers. Aptar Closures is also evolving its product offering to make it more sustainable for example through light weighting, use of post-consumer recycled (PCR) resin, thermoplastic elastomers (TPE) flow control or by adding features, such as tethered closures and non-detachable tamper evident packaging for beverages. The company also has an increasing number of product solutions that address the increased use of flexible packaging formats.
Food
Sales to the food market accounted for approximately 53% of the segment’s total net sales in 2024 and primarily include sales of dispensing closures, including those utilizing elastomeric flow-control components, and absorbent and non-absorbent food service trays.
Product applications for dispensing closures include sauces, condiments, infant nutrition and other food products. The company also leverages the company’s material science technology to sell and further develop packaging solutions to the food service market to enhance the shelf life of those products.
Beverage
Sales to the beverage market accounted for approximately 21% of the segment’s total net sales in 2024 and primarily include sales of dispensing closures, including those utilizing elastomeric flow-control components.
Sales of dispensing closures to the beverage market have increased over the last several years due to growing consumer demand for convenient packaging solutions, while brands have embraced dispensing closures as a key product differentiator through enhanced functionality, catering on-the-go and single-serve formats. Examples of beverage products utilizing dispensing closures include bottled water, sport and energy drinks, juices and concentrated water flavorings.
Personal Care
Sales to the personal care market accounted for approximately 19% of the segment’s total net sales in 2024 and primarily include sales of dispensing closures for standard and custom applications.
Hair care, body and facial skin care products in these spaces use dispensing closures to provide convenience, function, and style. Sustainability, e-commerce, and value providing solutions is what the company sees as the key drivers for growth in these markets.
Other
Sales to the beauty, home care and healthcare markets accounted for approximately 7% of the segment’s total net sales in 2024 and primarily include sales of dispensing closures for dish care, and other products to provide convenience, function, and style.
Customers
The company has approximately 5,000 customers.
International Business
The company is geographically diverse with manufacturing and sales operations in Asia, Europe, Latin America (including Mexico) and North America. Europe is the company’s largest region in terms of sales, where sales based on shipped to locations for the years ended December 31, 2024, were approximately 49% of its consolidated sales. Asia and Latin America when aggregated represented approximately 19% of the company’s consolidated sales for the years ended December 31, 2024. Although Europe represents the largest region for it in terms of sales, the company’s beauty and pharmaceutical customers often export its finished products using its technology around the world for consumption. The company is a net exporter of goods from Europe and a net importer of goods to the North American, Asian and Latin American regions.
Research and Development Expenses
The company’s research and development costs included $582.2 million for the year ended December 31, 2024.
Government Regulation
The company has established an innovation team that focuses on designing for and converting into more sustainable options like post-consumer recycled (PCR) resin and Food and Drug Administration approved resin alternatives.
History
AptarGroup, Inc. was incorporated in Delaware in 1992.
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.
